Mucoadhesive Buccal Patches Containing Resveratrol and/or Erythromycin-Loaded Lipid Microparticles as a Potential Targeted Strategy for the Prevention and Management of MRONJ in Patients Undergoing Oral Surgery
The proposed buccal patches are viable candidates for further clinical trials aimed at evaluating both the effectiveness of locoregional antibiotic treatment and the usefulness of the co-administration of RSV and ERY.
Authors
- Alessandro Presentato (ORCID: https://orcid.org/0000-0002-4794-0599)
- Giada Tranchida (ORCID: https://orcid.org/0000-0003-2697-982X)
- Giulia Di Prima (ORCID: https://orcid.org/0000-0002-3240-2704)
- Giovanna Giuliana (ORCID: https://orcid.org/0000-0002-5898-6373)
- Viviana De (ORCID: https://orcid.org/0000-0002-5186-1244)
- Cecilia La Mantia
- Giuseppina Campisi
Institutions
- University of Palermo (IT)
Publication Details
- Journal
- Antibiotics
- Published
- 2026-02-02
- DOI
- https://doi.org/10.3390/antibiotics15020151
- Primary Topic
- Advanced Drug Delivery Systems
- Type
- article
- Field-Weighted Citation Impact
- 0.00